Correlation Between Navidea Biopharmaceutica and Sigilon Therapeutics

Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and Sigilon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and Sigilon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Navidea Biopharmaceuticals and Sigilon Therapeutics, you can compare the effects of market volatilities on Navidea Biopharmaceutica and Sigilon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of Sigilon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and Sigilon Therapeutics.

Diversification Opportunities for Navidea Biopharmaceutica and Sigilon Therapeutics

0.0

Correlation Coefficient

Navidea Biopharmaceutica  Sigilon Therapeutics

Pay attention - limited upside

The 3 months correlation between Navidea and Sigilon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and Sigilon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sigilon Therapeutics and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with Sigilon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sigilon Therapeutics has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and Sigilon Therapeutics go up and down completely randomly.

Pair Corralation between Navidea Biopharmaceutica and Sigilon Therapeutics

If you would invest (100.00) in Sigilon Therapeutics on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Sigilon Therapeutics or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Navidea Biopharmaceuticals  vs.  Sigilon Therapeutics

Navidea Biopharmaceutica

Risk-Adjusted Performance

Very Weak

Over the last 90 days Navidea Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Navidea Biopharmaceutica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sigilon Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sigilon Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Sigilon Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Navidea Biopharmaceutica and Sigilon Therapeutics

The main advantage of trading using opposite Navidea Biopharmaceutica and Sigilon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, Sigilon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sigilon Therapeutics will offset losses from the drop in Sigilon Therapeutics' long position.

The idea behind Navidea Biopharmaceuticals and Sigilon Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.